Expert Consensus on the Application of Artificial Liver Blood Purification System in the Treatment of Severe and Critical COVID-19
Liang Chen,Yongping Chen,Yuemei Chen,Mingliang Cheng,Xiangchun Ding,Xiaoguang Dou,Weibo Du,Jianhe Gan,Hainv Gao,Zhiliang Gao,Jiawei Geng,Guozhong Gong,Yujuan Guan,Peng Hu,Yaoren Hu,Jianrong Huang,Jianning Jiang,Ying'an Jiang,Jun Li,Jiabin Li,Jianguo Li,Lanjuan Li,Yongguo Li,Feng Lin,Shourong Liu,Yingxia Liu,Qinghua Lu,Zhen Ma,Xiaorong Mao,Qinghua Meng,Liang Peng,Huiying Rao,Hong Ren,Jia Shang,Guoping Sheng,Jifang Sheng,Hongli Song,Zhijun Su,Lingling Tang,Hong Tang,Guiqiang Wang,Kai Wang,Xiaoping Wu,Qing Xie,Kaijin Xu,Xiaowei Xu,Dongliang Yang,Juzhen Ye,Liang Yu,Liaoyun Zhang,Wenhong Zhang,Yuexin Zhang,Huafen Zhang,Yimin Zhang,Caiyan Zhao,Yingren Zhao,Xin Zheng,Jiansheng Zhu,Mengfei Zhu
DOI: https://doi.org/10.1097/im9.0000000000000021
2020-01-01
Abstract:The prevention and treatment of COVID-19 nationwide has entered a tackling phase. Effective treatment of severe and critically ill patients is the key to reducing the fatality of the disease. The artificial liver blood purification system can remove inflammatory factors, alleviate the damage of the inflammatory response to the body, and has important value for the treatment of severe COVID-19. Led by Academician Lanjuan Li, based on the experience of treating patients across the country, integrating the opinions of experts from all over the country, the center summarized and formulated the consensus including the basic principles, treatment indications, relative contraindications, mode selection, monitoring indicators, and efficacy evaluation of artificial liver, which provides reference for treatment of severe COVID-19 patients.